Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Fallopian Tube Mucinous Adenocarcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Fallopian Tube Serous Adenocarcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Fallopian Tube Transitional Cell Carcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Fallopian Tube Carcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Mucinous Adenocarcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Seromucinous Carcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Serous Adenocarcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Transitional Cell Carcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Undifferentiated Ovarian Carcinoma	Mayo Clinic	P2	B (59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Carcinoma	Mayo Clinic	P2	B (59)
Oxaliplatin Aggressive B-Cell Non-Hodgkin Lymphoma	Shanghai EpimAb Biotherapeutics Co., Ltd.	P2	B (59)
Oxaliplatin MALT Lymphoma	Izidore Lossos, MD	P2	B (59)
Oxaliplatin High Grade B-Cell Lymphoma	City of Hope Medical Center	P2	B (59)
Oxaliplatin Triple-Negative Breast Carcinoma	Pfizer	P2	B (59)
Panobinostat Breast Cancer	Dana-Farber Cancer Institute	P2	B (59)
Pdc-1421 Major Depressive Disorder	BioLite, Inc.	P2	B (59)
Pegylated-Interferon .Alfa. 2B (Peg-Ifn) Melanoma	Hassane M. Zarour, MD	P2	B (59)
Pembrolizumab Anal Carcinoma	Dustin Deming	P2	B (59)
Pembrolizumab Cholangiocarcinoma	GV20 Therapeutics	P2	B (59)
Pembrolizumab Colorectal Adenocarcinoma	Salubris Biotherapeutics Inc	P2	B (59)
Pembrolizumab Neuroendocrine Neoplasm	University of Michigan Rogel Cancer Center	P2	B (59)
Pentostatin Graft Versus Host Disease	National Heart, Lung, and Blood Institute (NHLBI)	P2	B (59)
Pentoxifylline Major Depressive Disorder	Hawler Medical University	P2	B (59)
Petosemtamab Non-Small Cell Lung Carcinoma	Merus B.V.	P2	B (59)

Showing 2401 to 2425 of 13,155 assets

PreviousPage 97 of 527Next